ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

3.30
Delayed Data
As of 4:00pm ET
 +0.04 / +1.23%
Today’s Change
2.66
Today|||52-Week Range
7.25
-30.08%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for ZIOPHARM Oncology Inc have a median target of 6.50, with a high estimate of 7.50 and a low estimate of 4.00. The median estimate represents a +96.97% increase from the last price of 3.30.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in ZIOPHARM Oncology Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.08
Sales
$0.00
Reporting Date
Feb 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 81.78%
 
 
 
 
 
 
Growthannually -172.40%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.